These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7853345)

  • 1. Chromophore-modified antitumor anthracenediones: synthesis, DNA binding, and cytotoxic activity of 1,4-bis[(aminoalkyl)amino]benzo[g]-phthalazine-5,10-diones.
    Gandolfi CA; Beggiolin G; Menta E; Palumbo M; Sissi C; Spinelli S; Johnson F
    J Med Chem; 1995 Feb; 38(3):526-36. PubMed ID: 7853345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
    Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
    J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
    De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
    Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones.
    Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Luzikov YN; Sinkevich YB; Kovalenko LV; Buyanov VN; Balzarini J; Huang FC; Lin JJ; Huang HS; Shtil AA; Preobrazhenskaya MN
    Bioorg Med Chem; 2009 Mar; 17(5):1861-9. PubMed ID: 19208482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
    J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.
    Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C
    J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32P-postlabelling analysis of adducts formed by mitoxantrone and ametantrone with DNA and homopolydeoxyribonucleotides after enzymatic activation.
    Dackiewicz P; Skladanowski A; Konopa J
    Chem Biol Interact; 1995 Nov; 98(2):153-66. PubMed ID: 8548855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthracenedione antineoplastic agent effects on drug metabolism in vitro and in vivo: relationship between structure and mechanism of inhibition.
    Kharasch ED; Wendel NK; Novak RF
    Fundam Appl Toxicol; 1987 Jul; 9(1):18-25. PubMed ID: 3114031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aza and diaza bioisosteric anthracene-9,10-diones as antitumor agents.
    Krapcho AP; Maresch MJ; Hacker MP; Menta E; Oliva A; Giuliani FC; Spinelli S
    Acta Biochim Pol; 1995; 42(4):427-32. PubMed ID: 8852333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and calculated properties of some 1,4-bis(amino)anthracene-9,10-diones.
    Morley JO; Furlong PJ
    Org Biomol Chem; 2006 Nov; 4(21):4005-14. PubMed ID: 17047882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterosubstituted anthracene-9,10-dione analogues. The synthesis and antitumor evaluation of 5,8-bis[(aminoalkyl)amino]naphtho[2,3-b] thiophene-4,9-diones.
    Krapcho AP; Petry ME; Hacker MP
    J Med Chem; 1990 Sep; 33(9):2651-5. PubMed ID: 2391703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
    Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
    J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new ionizable chromophore of 1,4-bis(alkylamino)benzo[g]phthalazine which interacts with DNA by intercalation.
    Pons M; Campayo L; Martínez-Balbas MA; Azorin F; Navarro P; Giralt E
    J Med Chem; 1991 Jan; 34(1):82-6. PubMed ID: 1992157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones as potential antileukemic agents.
    Stefanska B; Dzieduszycka M; Martelli S; Borowski E
    J Med Chem; 1989 Aug; 32(8):1724-8. PubMed ID: 2754697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of the binding of mitoxantrone, ametantrone and analogues to DNA: relationship with binding mode and anti-tumour activity.
    Denny WA; Wakelin LP
    Anticancer Drug Des; 1990 May; 5(2):189-200. PubMed ID: 2357264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Effects of Glycosylation and Etherification of the Side Chains of the Anticancer Drug Mitoxantrone.
    Shaul P; Steinbuch KB; Blacher E; Stein R; Fridman M
    ChemMedChem; 2015 Sep; 10(9):1528-38. PubMed ID: 26235383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides.
    Smith PJ; Blunt NJ; Desnoyers R; Giles Y; Patterson LH
    Cancer Chemother Pharmacol; 1997; 39(5):455-61. PubMed ID: 9054961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems.
    Krapcho AP; Landi JJ; Shaw KJ; Phinney DG; Hacker MP; McCormack JJ
    J Med Chem; 1986 Aug; 29(8):1370-3. PubMed ID: 3735305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenediones.
    de Isabella P; Palumbo M; Sissi C; Carenini N; Capranico G; Menta E; Oliva A; Spinelli S; Krapcho AP; Giuliani FC; Zunino F
    Biochem Pharmacol; 1997 Jan; 53(2):161-9. PubMed ID: 9037248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental antitumor activity of the Ce(IV)-mitoxantrone complex and its interaction with deoxyribonucleic acid.
    Wang H; Yang P; Tian Y; Zhang Z; Zhao C
    J Inorg Biochem; 1997 Nov; 68(2):117-21. PubMed ID: 9336970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.